Appendix 3B - Proposed issue of securities Update Summary Entity name NEURIZON THERAPEUTICS LIMITED Announcement Type Update to previous announcement Date of this announcement 16/11/2026 Reason for update to a previous announcement Maximum number of SPP Shares to be issued updated to 147,058,824....
Update - Proposed issue of securities - NUZ
Filed with ASX · · 9 pages · English
Summary by 6ix AI
Neurizon Therapeutics Limited has filed an update regarding a proposed issue of securities under a securities purchase plan. The maximum number of shares to be issued has been updated to reflect a potential oversubscription, allowing for a larger total than initially planned. The announcement also outlines the conditions and details of the offer, including the minimum and maximum acceptance values for investors. Proceeds from the proposed issue will be used for clinical and pre-clinical activities related to a specific trial.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Neurizon Therapeutics Limited on 6ix
Story so far
Earlier from Neurizon Therapeutics
- Notice of General Meeting/Proxy Form
- Prospectus
- Share Purchase Plan and Options Offer Open
- First Regimen I patient enters Active Treatment Extension
- R&D Facility Extension and Second Drawdown Completed
Later from Neurizon Therapeutics
All Neurizon Therapeutics news releasesFollow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics